NCT00335933View on ClinicalTrials.gov

Safety and Efficacy of Gabapentin in Postherpetic Neuralgia

PHASE3CompletedINTERVENTIONAL
Enrollment

378

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

July 31, 2007

Conditions
Neuralgia, Postherpetic
Interventions
DRUG

Gabapentin extended-release tablets

Trial Locations (1)

78704

PPD Development, Austin

Sponsors

Lead Sponsor

Depomed
All Listed Sponsors
lead

Depomed

INDUSTRY

NCT00335933 - Safety and Efficacy of Gabapentin in Postherpetic Neuralgia | Biotech Hunter | Biotech Hunter